Cyclodextrins in the Pharmaceutical Field
暂无分享,去创建一个
Jos H. Beijnen | Auke Bult | J. Beijnen | E. Uijtendaal | A. Bult | Otto Bekers | E. V. Uijtendaal | Willy J. M. Underberg | O. Bekers | W. Underberg
[1] K. A. Connors,et al. trans-Cinnamic acid--alpha-cyclodextrin system as studied by solubility, spectral, and potentiometric techniques. , 1980, Journal of pharmaceutical sciences.
[2] K. Uekama,et al. Cyclodextrins in drug carrier systems. , 1987, Critical reviews in therapeutic drug carrier systems.
[3] T. Osa,et al. Complexation of aromatic carboxylic acids with heptakis(2,6-di-O-methyl)cyclomaltoheptaose in chloroform and water , 1989 .
[4] T. Nagai,et al. Inclusion complex of cinnarizine withβ-cyclodextrin in aqueous solution and in solid state , 1984 .
[5] T. Nagai,et al. Properties of cyclodextrin polymer as a tabletting aid. , 1984, Chemical & pharmaceutical bulletin.
[6] I. Sanemasa,et al. A new method for determining cyclodextrin complex formation constants with electrolytes in aqueous medium. , 1988 .
[7] W. M. Atkinson,et al. Solute-induced circular dichroism: drug discrimination by cyclodextrin. , 1984, Analytical chemistry.
[8] F. Bright,et al. Thermodynamic study on the effects of beta-cyclodextrin inclusion with anilinonaphthalenesulfonates. , 1989, Analytical chemistry.
[9] K. Uekama,et al. Improvement in biopharmaceutics of prednisolone by β- and γ-cyclodextrins , 1984 .
[10] T Nagai,et al. Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent. , 1985, Journal of pharmaceutical sciences.
[11] J. Lach,et al. Interaction of pharmaceuticals with Schardinger dextrins. VI. Interactions of beta-cyclodextrin, sodium deoxycholate, and deoxycholic acid with amines and pharmaceutical agents. , 1966, Journal of pharmaceutical sciences.
[12] N. Bodor,et al. The effects of 2-hydroxypropyl-β-cyclodextrin on the solubility and stability of chlorambucil and melphalan in aqueous solution , 1989 .
[13] K. A. Connors,et al. Effect of cycloamyloses on apparent dissociation constants of carboxylic acids and phenols: equilibrium analytical selectivity induced by complex formation. , 1976, Journal of pharmaceutical sciences.
[14] Ying Hu,et al. Preparation and properties of inclusion compounds of ferrocene and its derivatives with cyclodextrins , 1988 .
[15] T. Nagai,et al. Evaluation of bioavailability upon oral administration of cinnarizine-beta-cyclodextrin inclusion complex to beagle dogs. , 1985, Chemical & pharmaceutical bulletin.
[16] Biopharmaceutical aspects of cyclodextrins , 1990 .
[17] Y. Aso,et al. Epimerization and racemization of some chiral drugs in the presence of cyclodextrin and liposomes. , 1989, Chemical & pharmaceutical bulletin.
[18] Terada Katsuhide,et al. Molecular behavior, dissolution characteristics and chemical stability of aspirin in the ground mixture and in the inclusion complex with di-O-methyl-β-cyclodextrin , 1986 .
[19] N. Çelebi,et al. A study of the inclusion complex of naproxen with β-cyclodextrin , 1988 .
[20] Mohammad A. Hassan,et al. Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrin , 1990 .
[21] H. Koinuma,et al. STRUCTUAL ELUCIDATION OF THE INCLUSION COMPLEXES OF TOLBUTAMIDE WITH α- AND β-CYCLODEXTRINS IN AQUEOUS SOLUTION , 1978 .
[22] M. Kajtár,et al. Complex formation of phenolphthalein and some related compounds with β-cyclodextrin , 1988 .
[23] K. Uekama,et al. Hydrolysis Rate of Ethyl Cinnamates in the Presence of Cyclodextrin , 1976 .
[24] L. Pannell,et al. Hydroxypropyl-β-cyclodextrin: preparation and characterization; effects on solubility of drugs , 1986 .
[25] C. Rhodes,et al. Potential Pharmaceutical Applications of a New Beta Cyclodextrin Derivative , 1988 .
[26] J. Lach,et al. Influence of cyclodextrins on ester hydrolysis. , 1968, Journal of pharmaceutical sciences.
[27] T Nagai,et al. Evaluation of cyclodextrin polymer as an additive for furosemide tablet. , 1984, Chemical & pharmaceutical bulletin.
[28] K. Koizumi,et al. Inclusion complexes of poorly water-soluble drugs with glucosyl-cyclodextrins. , 1987, Chemical & pharmaceutical bulletin.
[29] K. Harata,et al. CRYSTAL AND MOLECULAR STRUCTURE OF 2 : 2 (±) FLURBIPROFEN-β-CYCLODEXTRIN COMPLEX , 1983 .
[30] J. Ripmeester. Variable temperature CP/MAS13C NMR study of cyclodextrin complexes of benzaldehyde , 1988 .
[31] I. Sanemasa,et al. Association of Benzene and Alkylbenzenes with Cyclodextrins in Aqueous Medium , 1987 .
[32] K. Uekama,et al. Enhanced absorption of phenobarbital from suppositories containing phenobarbital-beta-cyclodextrin inclusion complex. , 1982, Chemical & pharmaceutical bulletin.
[33] H. Bundgaard,et al. Inclusion complexation of metronidazole benzoate with β-cyclodextrin and its depression of anhydrate-hydrate transition in aqueous suspensions , 1984 .
[34] F. Hirayama,et al. Inclusion Complexation of Prostaglandin F2α with α-and β-Cyclodextrins in Aqueous Solution , 1978 .
[35] F. Hirayama,et al. Effects of Cyclodextrins on the Hydrolysis of Prostacyclin and Its Methyl Ester in Aqueous Solution , 1981 .
[36] K. Uekama,et al. Enhancement of Oral Bioavailability of Spironolactone by β- and γ-Cyclodextrin Complexations , 1983 .
[37] D. Duchěne,et al. Improvement in availability and stability of a dermocorticoid by inclusion in β-cyclodextrin , 1988 .
[38] F. Hirayama,et al. Improvement of dissolution characteristics and chemical stability of prostaglandin E1 by .GAMMA.-cyclodextrin complexation. , 1984 .
[39] J. Beijnen,et al. Stabilization of mitomycins on complexation with cyclodextrins in aqueous acidic media , 1989 .
[40] B. D. Anderson,et al. Inclusion complexes of purine nucleosides with cyclodextrins. I, Complexation and stabilization of a dideoxypurine nucleoside with 2-hydroxypropyl-β-cyclodextrin , 1990 .
[41] D. Duchěne,et al. Inclusion of retinoic acid in β-cyclodextrin , 1989 .
[42] I. Sanemasa,et al. Association of naphthalene and its methyl derivatives with cyclodextrins in aqueous medium. , 1988 .
[43] T. Yotsuyanagi,et al. Effects of drug bindings on esterase activity of human serum albumin. Dissociation constants of the complexes between the protein and drugs such as N-arylanthranilic acids, coumarin derivatives and prostaglandins. , 1979, Chemical & pharmaceutical bulletin.
[44] G. Hardee,et al. The interaction of some coumarin anticoagulants with beta-cyclodextrin in phosphate buffers. , 1978, Pharmaceutica acta Helvetiae.
[45] K. Harata,et al. The Circular Dichroism Spectra of the β-Cyclodextrin Complex with Naphthalene Derivatives , 1975 .
[46] F. Hirayama,et al. Some physicochemical properties of branched β-cyclodextrins and their inclusion characteristics , 1989 .
[47] T. Imai,et al. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin. , 1985, Journal of pharmaceutical sciences.
[48] S. Hamai. Association of Inclusion Compounds of β-Cyclodextrin in Aqueous Solution , 1982 .
[49] A. Rassat,et al. Nitroxides. 87. ESR determination of the thermodynamic data for the association of two paramagnetic enantiomers with .beta.-cyclodextrin , 1979 .
[50] A. Karara,et al. Characterization, Dissolution and Diffusion Properties of Tolbutamide-β-Cyclodextrin Complex System , 1988 .
[51] S. Morimoto,et al. Cannabis. XV: Preparation and stability of Δ9-tetrahydrocannabinol-β-cyclodextrin inclusion complex , 1983 .
[52] F. Hirayama,et al. Utilization of Diethyl-β-Cyclodextin as a Sustained-Release Carrier for Isosorbide Dinitrate , 1988 .
[53] F. Cramer,et al. Formation of cyclodextrin inclusion compounds of stable nitroxide radicals as monitored by electron-spin resonance spectra , 1979 .
[54] R. Palepu,et al. Binding constants of .beta.-cyclodextrin/surfactant inclusion by conductivity measurements , 1989 .
[55] D. Frank,et al. Cyclodextrin nephrosis in the rat. , 1976, The American journal of pathology.
[56] D. Kristol,et al. Cyclodextrin inclusion complexes: studies of the variation in the size of alicyclic guests , 1989 .
[57] K. Uekama,et al. Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins , 1988 .
[58] F. Hirayama,et al. Improvements of dissolution characteristics and chemical stability of 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester by cyclodextrin complexation. , 1979, Journal of pharmaceutical sciences.
[59] OtagiriMasaki,et al. CIRCULAR DICHROISM STUDY ON INCLUSION COMPLEXES OF SOME PROSTAGLANDINS WITH α- AND β-CYCLODEXTRINS , 1977 .
[60] S. Hamai. Inclusion compounds in the systems of .beta.-cyclodextrin-alcohol-pyrene in aqueous solution , 1989 .
[61] B. Perly,et al. Anthraquinone sulphonate as a general‐purpose shift reagent for the NMR analysis of cyclodextrins , 1990 .
[62] Y. Inoue,et al. NMR Studies of Cyclodextrin Inclusion Complex , 1989 .
[63] N. Rajagopalan,et al. A study of the inclusion complex of amphotericin-B with γ-cyclodextrin , 1986 .
[64] V. Zecchi,et al. Availability of NSAIDH β‐Cyclodextrin Inclusion Complexes , 1989 .
[65] Y. Inoue,et al. Determination of the qualitative host-guest geometrical relationships in cyclomaltohexaose inclusion-complexes on the basis of measurements of intermolecular proton nuclear Overhauser effects , 1987 .
[66] F. Hirayama,et al. Improvement of chemical instability of prostacyclin in aqueous solution by complexation with methylated cyclodextrins , 1987 .
[67] J. Pitha. Enhanced water solubility of vitamins A, D, E, and K by substituted cycloamyloses. , 1981, Life sciences.
[68] I. Apostol,et al. Suppositories containing β-cyclodextrin complexes. I: Stability studies , 1984 .
[69] K. Uekama,et al. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro. , 1982, Journal of pharmacobio-dynamics.
[70] N. Purdie,et al. Solute-induced circular dichroism: complexation of achiral drugs with cyclodextrin. , 1984, Analytical chemistry.
[71] H. Ueda,et al. Microcalorimetric and chromatographic investigations of the binding of some pyridine derivatives to cyclodextrins. , 1988, Journal of pharmaceutical and biomedical analysis.
[72] F. Hirayama,et al. Effects of cyclodextrins on the acid hydrolysis of digoxin , 1982, The Journal of pharmacy and pharmacology.
[73] G. Patonay,et al. Determination of cyclodextrin formation constants using dynamic coupled-column liquid chromatography , 1989 .
[74] F. Hirayama,et al. Utilization of cyclodextrin complexation for separation of E, A, and B prostaglandins by ion-exchange liquid chromatography. , 1977, Journal of pharmaceutical sciences.
[75] Y. Nakai. Molecular Behavior of Medicinals in Ground Mixtures with Microcrystalline Cellulose and Cyclodextrins , 1986 .
[76] Kennath A. Connors. Cyclodextrins and their industrial uses: Dominique Duchêne (Editor), Editions de Santé, 19 rue Louis-le-Grand, 75002 Paris, France, 1987, 448 pages, ISBN 2-86411-019-9. , 1988 .
[77] K. Koizumi,et al. Enhancement of the hypnotic potency of barbiturates by inclusion complexation with beta-cyclodextrin. , 1980, Chemical & pharmaceutical bulletin.
[78] H. Bundgaard,et al. The influence of cyclodextrin complexation on the stability of betamethasone-17-valerate , 1984 .
[79] S. Szathmary. Determination of hydroxypropyl-beta-cyclodextrin in plasma and urine by size-exclusion chromatography with post-column complexation. , 1989, Journal of chromatography.
[80] M. E. Brown,et al. Introduction to Thermal Analysis , 1988 .
[81] M. L. Bender,et al. Acceleration of phenyl ester cleavage by cycloamyloses. A model for enzymic specificity , 1967 .
[82] F. Hirayama,et al. Some pharmaceutical properties of 3-hydroxypropyl- and 2,3-dihydroxypropyl-beta-cyclodextrins and their solubilizing and stabilizing abilities. , 1989, Chemical & pharmaceutical bulletin.
[83] F. Hirayama,et al. Utility of 2-hydroxypropyl-beta-cyclodextrin in an intramuscular injectable preparation of nimodipine. , 1990, Chemical & pharmaceutical bulletin.
[84] R. Bergeron,et al. The molecular disposition of sodium p-nitrophenolate in the cavities of cycloheptaamylose and cyclohexaamylose in solution , 1976 .
[85] M. Schwaller,et al. Kinetics and thermodynamics of the formation of inclusion complexes between cyclodextrins and DNA-intercalating agents. Inclusion of ellipticine in γ-cyclodextrin , 1989 .
[86] Y. Kotake,et al. Bimodal inclusion of nitroxide radicals by .beta.-cyclodextrin in water as studied by electron spin resonance and electron nuclear double resonance , 1989 .
[87] K. Uekama,et al. Analysis of interfacial transfer and absorption behavior of drugs following dissolution from beta-cyclodextrin complexes. , 1983, Chemical & pharmaceutical bulletin.
[88] F. Menger,et al. Aggregation in strong acid. A micelle of carbonium ions , 1979 .
[89] S. Lincoln,et al. Inclusion Complexes of the Cyclomalto-Oligosaccharides (Cyclodextrins) , 1988 .
[90] J. Szejtli,et al. Stabilisierung fettlöslicher Vitamine mit beta‐Cyclodextrin , 1980 .
[91] H. Nakanishi,et al. Circular dichroism spectra of the inclusion complexes of phlorizin in cyclodextrins , 1990 .
[92] A. Karara,et al. Characterization, dissolution and bioavailability in rats of ibuprofen-β-cyclodextrin complex system , 1986 .
[93] W. Saenger,et al. Inclusion Compounds. XIX.1a The Formation of Inclusion Compounds of α-Cyclodextrin in Aqueous Solutions. Thermodynamics and Kinetics , 1967 .
[94] Wolfram Saenger,et al. Cyclodextrin Inclusion Compounds in Research and Industry , 1980 .
[95] T. Matsue,et al. Cyclodextrin-Nitrophenol Systems Studied by Polarography , 1977 .
[96] I. Wadsö,et al. Microcalorimetric titration of β-cyclodextrine with adamantane-1-carboxylate , 1986 .
[97] B. Müller,et al. Solubilization of drugs by modified β-cyclodextrins , 1985 .
[98] J. Szejtli. Cyclodextrins and their inclusion complexes , 1982 .
[99] K. Uekama,et al. Stabilization of isosorbide 5-mononitrate in solid state by β-cyclodextrin complexation , 1985 .
[100] K. Uekama,et al. Effects of β- and γ-Cyclodextrins on Release of Betamethasone from Ointment Bases , 1984 .
[101] T. Nagai,et al. Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form. , 1975, Chemical & pharmaceutical bulletin.
[102] L. M. Schwartz,et al. Acid dissociation of cyclooctaamylose , 1982 .
[103] F. Hirayama,et al. Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives. , 1988, Chemical & pharmaceutical bulletin.
[104] F. Vincieri,et al. Inclusion complex formation of 1,8-dihydroxyanthraquinone with cyclodextrins in aqueous solution and in solid state. , 1988, Journal of pharmaceutical sciences.
[105] S. Harada,et al. Inclusion compounds of lankacidin-group antibiotics with cyclodextrins. , 1985, The Journal of antibiotics.
[106] F. Hirayama,et al. Inclusion Complexation of Prostaglandin F2α with γ-Cyclodextrin in Solution and Solid Phases , 1984 .
[107] R. Bergeron,et al. Dependence of cycloamylose-substrate binding on charge , 1978 .
[108] K. Terada,et al. New Methods for Preparing Cyclodextrin Inclusion Compounds. I. Heating in a Sealed Container , 1987 .
[109] M. Eftink,et al. Spectral displacement techniques for studying the binding of spectroscopically transparent ligands to cyclodextrins. , 1986, Analytical biochemistry.
[110] O. Corrigan,et al. Mechanism of drug dissolution rate enhancement from β‐cyclodextrin‐drug systems , 1982 .
[111] N. Higuchi,et al. Dissolution behavior of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone. , 1986, Chemical & pharmaceutical bulletin.
[112] K. Koizumi,et al. Isolation and characterization of hexakis(2,6-di-O-methyl)cyclomaltohexaose and octakis(2,6-di-O-methyl)cyclomalto-octaose, and their over-methylated homologues. , 1990 .
[113] K. Uekama,et al. Anomalous dissolution behavior of the diazepam — γ-cyclodextrin complex in polymer solutions , 1984 .
[114] M. Takada,et al. Preparation of Solid dispersion Systems of Disopyramide with Polyvinylpyrrolidone and γ-Cyclodextrin , 1988 .
[115] J. Nakayama,et al. Induced circular dichroism spectra of the cyclodextrin complexes with 2-Thioxo-1,3-benzodithiole and 2-Selenoxo-1,3-benzodithiole , 1990 .
[116] Y. Inoue,et al. Determination of the host-guest geometry in the inclusion complexes of cyclomalto-oligosaccharides with p-nitrophenol in solution , 1988 .
[117] S. P. Jones,et al. Polarographic detection of beta-cyclodextrin inclusion complexes , 1986 .
[118] K. Uekama,et al. New Perspectives in Cyclodextrin Pharmaceutical Applications , 1990 .
[119] J. Pitha. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients. , 1985, Journal of pharmaceutical sciences.
[120] J. Szejtli,et al. Aggregation of amphotericin B in the presence of γ‐cyclodextin , 1989 .
[121] K. Uekama,et al. Inclusion complexes of cinnamic acids with cyclodextrins. Mode of inclusion in aqueous solution. , 1975 .
[122] Kikuchi Masahiko,et al. Improvement of oral and rectal bioavailabilities of carmofur by methylated β-cyclodextrin complexations , 1987 .
[123] F. Hirayama,et al. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation. , 1983, Journal of pharmaceutical sciences.
[124] Y Horiuchi,et al. Design and in vitro evaluation of slow-release dosage form of piretanide: utility of beta-cyclodextrin:cellulose derivative combination as a modified-release drug carrier. , 1990, Journal of pharmaceutical sciences.
[125] F. Hirayama,et al. Improvement of dissolution and absorption characteristics of benzodiazepines by cyclodextrin complexation , 1983 .
[126] K. Kitamura,et al. Stabilization of AD-1590, a non-steroidal antiinflammatory agent, in suppository bases by beta-cyclodextrin complexation. , 1986, Chemical and pharmaceutical bulletin.
[127] T Nagai,et al. Bioavailability of powdered inclusion compounds of nonsteroidal antiinflammatory drugs with beta-cyclodextrin in rabbits and dogs. , 1978, Chemical & pharmaceutical bulletin.
[128] B. Hingerty,et al. “Induced-fit”-type complex formation of the model enzyme α-cyclodextrin , 1976 .
[129] K. Uekama,et al. Sustained release of buserelin acetate, a luteinizing hormone‐releasing hormone agonist, from an injectable oily preparation utilizing ethylated β‐cyclodextrin , 1989, The Journal of pharmacy and pharmacology.
[130] J. Szejtli,et al. Menadione-γ-cyclodextrin inclusion complex , 1985 .
[131] Y. Sasaki,et al. Inclusion compounds of cyclodextrin and azo dyes. IV(b): Nuclear magnetic resonance and circular dichroism spectra of γ-cyclodextrin and orange II in the solution state , 1984 .
[132] M. Kata,et al. Increasing the solubility of drugs through cyclodextrin complexation , 1987 .
[133] L. M. Schwartz,et al. Acid dissociation of cyclohexaamylose and cycloheptaamylose , 1980 .
[134] M. E. Brown,et al. Introduction to Thermal Analysis: Techniques and applications , 1988 .
[135] F. Hirayama,et al. Slow-release characteristics of diltiazem from ethylated beta-cyclodextrin complexes. , 1990, Journal of pharmaceutical sciences.
[136] L. Barcza,et al. Complex formation of phenol, aniline, and their nitro derivatives with β-cyclodextrin , 1988 .
[137] J. Szejtli. Dimethyl-β-cyclodextrin as parenteral drug carrier , 1983 .
[138] F. Hirayama,et al. Inclusion complexes of cyclodextrins with cinnamic acid derivatives: Dissolution and thermal behavior. , 1979 .
[139] S. Ismail,et al. Studies of Cyclodextrin Inclusion Complexes: I - Inclusion Complexes Between α- And β-Cyclodextrins and Chloramphenicol in Aqeuous Solutions , 1986 .
[140] F. Hirayama,et al. Determination of the Stability Constants for Inclusion Complexes of Cyclodextrins with Various Drug Molecules by High Performance Liquid Chromatography , 1978 .
[141] M. Huffman,et al. Comparison of tolbutamide β-cyclodextrin inclusion compounds and solid dispersions: Physicochemical characteristics and dissolution studies , 1990 .
[142] Y. Inoue,et al. N.m.r. studies of cycloamylose inclusion-complexes with p-substituted phenols , 1984 .
[143] A. Harada,et al. Preparation and properties of inclusion compounds of transition-metal complexes of cycloocta-1,5-diene and norbornadiene with cyclodextrins , 1989 .
[144] H. Koinuma,et al. Molecular dynamics of prostaglandin F2.ALPHA.-cyclodextrin complexes in aqueous solution. , 1980 .
[145] M. Brewster,et al. An intravenous toxicity study of 2-hydroxypropyl-β-cyclodextrin, a useful drug solubilizer, in rats and monkeys , 1990 .
[146] Masaki Yamasaki,et al. Inclusi on complexations of steroid hormones with cyclodextrins in water and in solid phase , 1982 .
[147] K. A. Connors,et al. Potentiometric study of molecular complexes of weak acids and bases applied to complexes of alpha-cyclodextrin with para-substituted benzoic acids. , 1982, Journal of pharmaceutical sciences.
[148] T. Arita,et al. Dissolution behavior and gastrointestinal absorption of dicumarol from solid dispersion systems of dicumarol-polyvinylpyrrolidone and dicumarol-beta-cyclodextrin. , 1983, Chemical & pharmaceutical bulletin.
[149] S. Hizukuri,et al. Some properties and the inclusion behavior of branched cyclodextrins. , 1988, Chemical & pharmaceutical bulletin.
[150] F. Hirayama,et al. Ethylated beta-cyclodextrins as hydrophobic drug carriers: sustained release of diltiazem in the rat. , 1987, Journal of pharmaceutical sciences.
[151] F. Hirayama,et al. MODIFICATION OF SUBSTITUENT EFFECT BY CYCLODEXTRIN COMPLEXATION IN ALKALINE HYDROLYSIS OF 7-SUBSTITUTED COUMARINS , 1981 .
[152] L. Szente,et al. Proceedings of the Eighth International Symposium on Cyclodextrins , 1982 .
[153] J. Lach,et al. SCHARDINGER DEXTRIN INTERACTION. IV. INHIBITION OF HYDROLYSIS BY MEANS OF MOLECULAR COMPLEX FORMATION. , 1964, Journal of pharmaceutical sciences.
[154] F. Hirayama,et al. Improvement of some pharmaceutical properties of nocloprost by β- and γ-Cyclodextrin Complexation , 1990 .
[155] N. Purdie,et al. Cyclodextrin complexation of barbiturates in aqueous solution. , 1984, Analytical chemistry.
[156] K. Kano,et al. Spectroscopic Study of Hydrophobic Interaction of Heterocyclic Amine N-Oxides with Cyclodextrins. , 1988 .
[157] M. Hashida,et al. Effects of β-cyclodextrin and di-O-methyl-β-cyclodextrin on the percutaneous absorption of butylparaben, indomethacin and sulfanilic acid , 1986 .
[158] K. Uekama,et al. Simultaneous determination of complexation equilibrium constants for conjugated guest species by extended potentiometric titration method: on barbiturate-beta-cyclodextrin system. , 1976, Chemical & pharmaceutical bulletin.
[159] István Lukovits,et al. Theoretical investigation of inclusion complexes of β-cyclodextrin with alcohols , 1988 .
[160] H. Frijlink,et al. The effects of cyclodextrins on drugs absorption. I. In vitro observations , 1989 .
[161] J. Perrin,et al. Cycloheptaamylose-barbiturate inclusion complexes: solubility and circular dichroism studies. , 1972, Journal of pharmaceutical sciences.
[162] S. Davis,et al. Modification of the aqueous solubility and stability of progabide , 1989 .
[163] A. Kaifer,et al. The interactions of surfactant viologens with cyclodextrins , 1989 .
[164] F. Hirayama,et al. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins. , 1984, Chemical & pharmaceutical bulletin.
[165] B. D. Anderson,et al. Inclusion complexes of purine nucleosides with cyclodextrins II. Investigation of inclusion complex geometry and cavity microenvironment , 1990 .
[166] Y. Inoue,et al. A Molecular Orbital Study of Cyclodextrin Inclusion Complexes. I. The Calculation of the Dipole Moments of α-Cyclodextrin Aromatic Guest Complexes , 1988 .
[167] T. Nagai,et al. Influence of inclusion of nonsteroidal antiinflammatory drugs with beta-cyclodextrin on the irritation to stomach of rats upon oral administration. , 1978, Chemical & pharmaceutical bulletin.
[168] K. A. Connors,et al. Stoichiometric model of α-cyclodextrin complex formation , 1980 .
[169] K. Uekama,et al. Improvement in the percutaneous absorption of beclomethasone dipropionate by γ‐cyclodextrin complexation , 1985, The Journal of pharmacy and pharmacology.